At a glance
ClinicalIndex Comparison RecordN/ACompleted· 22 enrolled
Drug / intervention
Histamine +4 moredrug
Likely dose
Histamine 6 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Skin Prick Test of KeraStat® Cream
In Brief
A clinical study evaluating KeraStat® Cream, KeraStat Gel, and 3 other interventions for Hypersensitivity. Completed, enrolled 22 participants across 1 site.
Detailed Summary
To evaluate the potential for a humoral reaction to KeraStat Cream compared to a predicate device using the skin prick test.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypersensitivity
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartJul 2019
Primary CompletionAug 2019
First PostedAug 2019
TodayJul 2026
First PostedAug 15, 2019
Enrollment StartJul 29, 2019
Primary CompletionAug 2, 2019
TodayJul 2, 2026
Enrollment to primary: 3 daysPosted 6.9 years ago
Interventions
KeraStat® Creamdevice
Administered 0.025 gm of KeraStat Cream per subject on day 1 of the study.
KeraStat Geldevice
Administered 0.025 gm of KeraStat Gel per subject on day 1 of the study.
Biafinedevice
Administered 0.025 gm of Biafine per subject on day 1 of the study.
Histaminedrug
Administered 1 drop of Histamine Dihydrocl (6 mg/mL) per subject on day 1 of the study.
Saline (0.9% NaCl)drug
Administered 1 drop of saline per subject on day 1 of the study.